Matches in Wikidata for { <http://www.wikidata.org/entity/Q93043588> ?p ?o ?g. }
- Q93043588 description "article scientifique publié en 2019" @default.
- Q93043588 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q93043588 description "scientific article published on 29 August 2019" @default.
- Q93043588 description "wetenschappelijk artikel" @default.
- Q93043588 description "наукова стаття, опублікована 29 серпня 2019" @default.
- Q93043588 name "Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial" @default.
- Q93043588 name "Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial" @default.
- Q93043588 type Item @default.
- Q93043588 label "Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial" @default.
- Q93043588 label "Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial" @default.
- Q93043588 prefLabel "Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial" @default.
- Q93043588 prefLabel "Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial" @default.
- Q93043588 P1433 Q93043588-7E599FA3-2BFB-4B80-8AD6-43F261A7D70E @default.
- Q93043588 P1476 Q93043588-F8DF7BFD-0D5C-46E5-84FF-96FABBC81CD5 @default.
- Q93043588 P2093 Q93043588-078E620F-2F88-4B36-9E23-9E6F8A430F81 @default.
- Q93043588 P2093 Q93043588-15F76ED8-4A9B-426B-B882-83FE7D5D7EDC @default.
- Q93043588 P2093 Q93043588-475353E6-C098-4F4D-9545-BC9ED515B223 @default.
- Q93043588 P2093 Q93043588-5B3EC2F7-0216-4A15-9FA8-CA2C6E45882F @default.
- Q93043588 P2093 Q93043588-5D6DE4D0-EB43-45BB-82D2-BE089BCC460A @default.
- Q93043588 P2093 Q93043588-608BB0B2-3C96-4428-9313-145F23C79530 @default.
- Q93043588 P2093 Q93043588-64F623F3-CD0D-4A2A-A3F5-D39B9613F6E7 @default.
- Q93043588 P2093 Q93043588-70943047-47F9-4881-A0EC-332BBBCA622C @default.
- Q93043588 P2093 Q93043588-80B9BC39-ED7D-452E-B90D-1B6D616CB44A @default.
- Q93043588 P2093 Q93043588-8884B7F5-BA29-4AD1-A54D-6F4F23F9AC78 @default.
- Q93043588 P2093 Q93043588-89211667-AD06-4B69-978E-78591AB995B5 @default.
- Q93043588 P2093 Q93043588-8B9DA0B2-CE9D-4913-85D5-3CCF186BFB93 @default.
- Q93043588 P2093 Q93043588-9437BB5B-E658-449D-B44C-E57E9FC6F20A @default.
- Q93043588 P2093 Q93043588-970B3D7E-0832-4669-93BE-CF3E2AE3FFEB @default.
- Q93043588 P2093 Q93043588-D50FF92A-F1AB-41DD-9A59-DE3ACCF023DA @default.
- Q93043588 P2093 Q93043588-E49BA378-8613-4747-BF7C-9197C21B2520 @default.
- Q93043588 P2093 Q93043588-E5BDE951-8B75-4EB9-B964-290195FFC33F @default.
- Q93043588 P2093 Q93043588-EAE87084-1655-4DED-9646-F890505A7FF5 @default.
- Q93043588 P2093 Q93043588-FF4F3C74-154B-4454-A70C-105AF9BFC238 @default.
- Q93043588 P2860 Q93043588-14677AFF-5706-4D7D-AF89-95045625A181 @default.
- Q93043588 P2860 Q93043588-19167FEE-E3D2-49CC-9FB1-B0336994CEF3 @default.
- Q93043588 P2860 Q93043588-26F5D329-2C87-462E-BF34-C4C70423FF48 @default.
- Q93043588 P2860 Q93043588-2BCDA188-018E-4805-823F-9093A873FEEA @default.
- Q93043588 P2860 Q93043588-30EEED1C-824E-4483-8DF6-95FA9383F473 @default.
- Q93043588 P2860 Q93043588-4B60450E-2B29-4F83-8C50-9430522CA8C3 @default.
- Q93043588 P2860 Q93043588-4F4D84B0-0B2B-4F4F-AB2A-B654AE09FFD6 @default.
- Q93043588 P2860 Q93043588-5970BB01-D649-4C84-B1B0-A6B2DCBBAD02 @default.
- Q93043588 P2860 Q93043588-612C858D-1144-4A6E-BF32-F0B6FA32BBD9 @default.
- Q93043588 P2860 Q93043588-68091422-763D-49C3-B95C-15F0B5F823D7 @default.
- Q93043588 P2860 Q93043588-69CB4AA7-DE73-488D-9362-92582B894674 @default.
- Q93043588 P2860 Q93043588-785A4BD9-ED66-4C0F-AC1B-B8F7228B66F0 @default.
- Q93043588 P2860 Q93043588-7EB2C0CD-656D-43C5-BFEE-FD2EBA099663 @default.
- Q93043588 P2860 Q93043588-87098790-B324-402A-A789-445667BDD272 @default.
- Q93043588 P2860 Q93043588-870F1D4A-B6BD-4138-ACB7-418D285CC035 @default.
- Q93043588 P2860 Q93043588-90ADADAD-1483-4E0E-BF49-91AE1B134A23 @default.
- Q93043588 P2860 Q93043588-9CC6338F-93DD-4261-8F18-4348749E28EC @default.
- Q93043588 P2860 Q93043588-AB116B4C-1578-4A4E-9EF5-14DA67FE4A7C @default.
- Q93043588 P2860 Q93043588-B375EE91-FF30-417B-B538-0909DDD85F54 @default.
- Q93043588 P2860 Q93043588-C8C635E5-EF1E-42CD-A9C4-9FEFDA1188B3 @default.
- Q93043588 P2860 Q93043588-CA628600-CC7F-437D-8A08-A9FFEF40EB51 @default.
- Q93043588 P2860 Q93043588-CDA48135-88B3-49AF-BA90-28F64A730CC5 @default.
- Q93043588 P2860 Q93043588-D1FB778F-4649-4B33-AE78-AD486D055783 @default.
- Q93043588 P2860 Q93043588-F86D64C6-B59A-43EE-97C3-9133A307E8F1 @default.
- Q93043588 P2860 Q93043588-FA31F9EE-59A0-4DC5-B742-22D8290F1E47 @default.
- Q93043588 P2860 Q93043588-FEF10A45-7EBD-476C-9EC6-421CEE47907B @default.
- Q93043588 P304 Q93043588-EFB16518-A090-482E-A356-B1B67C50212A @default.
- Q93043588 P31 Q93043588-800F3407-94F7-4A0F-AA43-9AB5BC6DE487 @default.
- Q93043588 P356 Q93043588-4813665E-F976-4BC3-9FA0-6ED568B43609 @default.
- Q93043588 P433 Q93043588-8705D702-F0D1-410B-9D1E-C1C889D7F2EA @default.
- Q93043588 P478 Q93043588-8195A20B-625B-4050-B6C4-422135727BE2 @default.
- Q93043588 P50 Q93043588-21157D58-4BA5-4B74-850C-B7921D40A7C6 @default.
- Q93043588 P577 Q93043588-E7ABA6DE-D711-42D1-AC1D-DF88E41CE50D @default.
- Q93043588 P698 Q93043588-B95397DE-5BE4-4B2F-AD73-27E6EAA6C40D @default.
- Q93043588 P921 Q93043588-40C28060-3E64-408D-98FA-00BA6B9AE287 @default.
- Q93043588 P921 Q93043588-9F165A3D-B47F-4DEF-9011-9AD0D3C6631A @default.
- Q93043588 P921 Q93043588-BF1F0698-010D-478C-9CA4-15B23A0B4DDF @default.
- Q93043588 P356 S1470-2045(19)30515-7 @default.
- Q93043588 P698 31474354 @default.
- Q93043588 P1433 Q13747613 @default.
- Q93043588 P1476 "Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial" @default.
- Q93043588 P2093 "AVANOVA investigators" @default.
- Q93043588 P2093 "Anders Krog Vistisen" @default.
- Q93043588 P2093 "Anja Ør Knudsen" @default.
- Q93043588 P2093 "Bente Lund" @default.
- Q93043588 P2093 "Elisabeth Åvall Lundqvist" @default.
- Q93043588 P2093 "Gabriel Lindahl" @default.
- Q93043588 P2093 "Gitte-Bettina Nyvang" @default.
- Q93043588 P2093 "Henrik Roed" @default.
- Q93043588 P2093 "Johanna U Mäenpää" @default.
- Q93043588 P2093 "Line Bjørge" @default.
- Q93043588 P2093 "Maarit Anttila" @default.
- Q93043588 P2093 "Mansoor Raza Mirza" @default.
- Q93043588 P2093 "Maria Dimoula" @default.
- Q93043588 P2093 "Michael J Birrer" @default.
- Q93043588 P2093 "Rene dePont Christensen" @default.
- Q93043588 P2093 "Susanne Malander" @default.
- Q93043588 P2093 "Synnöve Staff" @default.
- Q93043588 P2093 "Theresa L Werner" @default.
- Q93043588 P2093 "Ulla Peen" @default.
- Q93043588 P2860 Q26741755 @default.
- Q93043588 P2860 Q27853070 @default.
- Q93043588 P2860 Q33408750 @default.
- Q93043588 P2860 Q33435836 @default.
- Q93043588 P2860 Q33719652 @default.
- Q93043588 P2860 Q34030022 @default.
- Q93043588 P2860 Q34155719 @default.